Biology Reference
In-Depth Information
primary tumor thereby reinforcing its malignant behavior will definitely constitute
the scope of upcoming research.
Acknowledgments This work was supported by NIH grants R01 CA 129484 and R01 CA 105412
(to J.P.Q) and NIH/NCRR/STSI Grant UL1 RR025774 (Pilot Award to E.I.D.).
References
Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM (2006a) Matrix metalloproteinase-9
from bone marrow-derived cells contributes to survival but not growth of tumor cells in the
lung microenvironment. Cancer Res 66(1):259-266
Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz
DR, Moin K, Sloane BF, Matrisian LM (2006b) Analysis of host- and tumor-derived protei-
nases using a custom dual species microarray reveals a protective role for stromal matrix
metalloproteinase-12 in non-small cell lung cancer. Cancer Res 66(16):7968-7975
Adley BP, Gleason KJ, Yang XJ, Stack MS (2009) Expression of membrane type 1 matrix
metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell
carcinoma. Gynecol Oncol 112(2):319-324
Aggarwal BB, Gehlot P (2009) Inflammation and cancer: how friendly is the relationship for
cancer patients? Curr Opin Pharmacol 9(4):351-369
Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not
for angiogenesis: role of bone marrow-derivedmyelomonocytic cells. Cancer Cell 13(3):193-205
Aird WC (2007a) Phenotypic heterogeneity of the endothelium: I. Structure, function, and
mechanisms. Circ Res 100(2):158-173
Aird WC (2007b) Phenotypic heterogeneity of the endothelium: II representative vascular beds.
Circ Res 100(2):174-190
Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ (2000) Intravascular origin
of metastasis from the proliferation of endothelium-attached tumor cells: a new model for
metastasis. Nat Med 6(1):100-102
Almholt K, Green KA, Juncker-Jensen A, Nielsen BS, Lund LR, Romer J (2007) Extracellular
proteolysis in transgenic mouse models of breast cancer. J Mammary Gland Biol Neoplasia
12(1):83-97
Almholt K, Johnsen M (2003) Stromal cell involvement in cancer. Recent Results Cancer Res
162:31-42
Andarawewa KL, Boulay A, Masson R, Mathelin C, Stoll I, Tomasetto C, Chenard MP, Gintz M,
Bellocq JP, Rio MC (2003) Dual stromelysin-3 function during natural mouse mammary tumor
virus-ras tumor progression. Cancer Res 63(18):5844-5849
Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009a) Modulation of invasive
properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysopho-
spholipid signaling. Mol Carcinog 48(10):910-919
Annabi B, Laflamme C, Sina A, Lachambre MP, Beliveau R (2009b) A MT1-MMP/NF-kappaB
signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma
cells. J Neuroinflammation 6:8
Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, Beliveau R
(2008) Tumor environment dictates medulloblastoma cancer stem cell expression and invasive
phenotype. Mol Cancer Res 6(6):907-916
Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP (2007) Human neutrophils uniquely release
TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci
USA 104(51):20262-20267
Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP (2009)
Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation
